131 related articles for article (PubMed ID: 34257420)
1. Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer.
Hamilton JG; Symecko H; Spielman K; Breen K; Mueller R; Catchings A; Trottier M; Salo-Mullen EE; Shah I; Arutyunova A; Batson M; Gebert R; Pundock S; Schofield E; Offit K; Stadler ZK; Cadoo K; Carlo MI; Narayan V; Reiss KA; Robson ME; Domchek SM
Genet Med; 2021 Nov; 23(11):2105-2113. PubMed ID: 34257420
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
Culver JO; Ricker CN; Bonner J; Kidd J; Sturgeon D; Hodan R; Kingham K; Lowstuter K; Chun NM; Lebensohn AP; Rowe-Teeter C; Levonian P; Partynski K; Lara-Otero K; Hong C; Morales Pichardo J; Mills MA; Brown K; Lerman C; Ladabaum U; McDonnell KJ; Ford JM; Gruber SB; Kurian AW; Idos GE
Cancer; 2021 Apr; 127(8):1275-1285. PubMed ID: 33320347
[TBL] [Abstract][Full Text] [Related]
3. Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.
Ramsey ML; Tomlinson J; Pearlman R; Abushahin L; Aeilts A; Chen HZ; Chen Y; Compton A; Elkhatib R; Geiger L; Hays J; Jeter J; Jin N; Malalur P; Roychowdhury S; Ruple J; Prebish J; Stanich PP; Hampel H
Fam Cancer; 2023 Jan; 22(1):91-97. PubMed ID: 35713757
[TBL] [Abstract][Full Text] [Related]
4. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
Giri VN; Obeid E; Hegarty SE; Gross L; Bealin L; Hyatt C; Fang CY; Leader A
Prostate; 2018 Sep; 78(12):879-888. PubMed ID: 29655297
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
Breen KE; Symecko H; Spielman K; Gebert R; Shah IH; Pundock S; Batson M; Narayan VK; Stadler ZK; Autio KA; Abida W; Danila DC; Scher HI; Morris MJ; Hamilton JG; Robson ME; Domchek SM; Carlo MI
J Urol; 2023 May; 209(5):918-927. PubMed ID: 36974724
[TBL] [Abstract][Full Text] [Related]
6. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
[TBL] [Abstract][Full Text] [Related]
7. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
Loeb S; Keith SW; Cheng HH; Leader AE; Gross L; Sanchez Nolasco T; Byrne N; Hartman R; Brown LH; Pieczonka CM; Gomella LG; Kelly WK; Lallas CD; Handley N; Mille PJ; Mark JR; Brown GA; Chopra S; McClellan A; Wise DR; Hollifield L; Giri VN
JCO Precis Oncol; 2024 Mar; 8():e2300552. PubMed ID: 38452310
[TBL] [Abstract][Full Text] [Related]
8. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
[TBL] [Abstract][Full Text] [Related]
10. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
Vlaming M; Bleiker EMA; van Oort IM; Kiemeney LALM; Ausems MGEM
BMC Cancer; 2022 Dec; 22(1):1365. PubMed ID: 36581909
[TBL] [Abstract][Full Text] [Related]
11. Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations.
Underhill-Blazey M; Blonquist T; Chittenden A; Pozzar R; Nayak M; Lansang K; Hong F; Garber J; Stopfer JE
J Genet Couns; 2021 Feb; 30(1):268-282. PubMed ID: 32851753
[TBL] [Abstract][Full Text] [Related]
12. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
Esteban I; Vilaró M; Adrover E; Angulo A; Carrasco E; Gadea N; Sánchez A; Ocaña T; Llort G; Jover R; Cubiella J; Servitja S; Herráiz M; Cid L; Martínez S; Oruezábal-Moreno MJ; Garau I; Khorrami S; Herreros-de-Tejada A; Morales R; Cano JM; Serrano R; López-Ceballos MH; González-Santiago S; Juan-Fita MJ; Alonso-Cerezo C; Casas A; Graña B; Teulé A; Alba E; Antón A; Guillén-Ponce C; Sánchez-Heras AB; Alés-Martínez JE; Brunet J; Balaguer F; Balmaña J
Psychooncology; 2018 Jun; 27(6):1530-1537. PubMed ID: 29498768
[TBL] [Abstract][Full Text] [Related]
13. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
Loeb S; Cheng HH; Leader A; Gross L; Nolasco TS; Byrne N; Wise DR; Hollifield L; Brown LH; Slater E; Pieczonka C; Gomella LG; Kelly WK; Trabulsi EJ; Handley N; Lallas CD; Chandrasekar T; Mille P; Mann M; Mark JR; Brown G; Chopra S; Wasserman J; Phillips J; Somers P; Giri VN
Contemp Clin Trials; 2022 Aug; 119():106821. PubMed ID: 35710085
[TBL] [Abstract][Full Text] [Related]
14. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.
Russo J; McDougall C; Bowler N; Shimada A; Gross L; Hyatt C; Kelly WK; Calvaresi A; Handley NR; Hirsch IH; Izes JK; Lallas CD; Mann M; Mark JR; Mille PJ; Preate D; Trabulsi EJ; Tsang M; Chandrasekar T; Weiner PR; Gomella LG; Giri VN
JCO Precis Oncol; 2021; 5():. PubMed ID: 34589662
[TBL] [Abstract][Full Text] [Related]
15. Clinical Multigene Testing for Prostate Cancer.
Berro T; Barrett E; AlDubayan SH
Urol Clin North Am; 2021 Aug; 48(3):297-309. PubMed ID: 34210486
[TBL] [Abstract][Full Text] [Related]
16. Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.
Pederson HJ; Gopalakrishnan D; Noss R; Yanda C; Eng C; Grobmyer SR
J Am Coll Surg; 2018 Apr; 226(4):560-565. PubMed ID: 29360614
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer.
Scheinberg T; Goodwin A; Ip E; Linton A; Mak B; Smith DP; Stockler MR; Strach MC; Tran B; Young AL; Zhang AY; Mahon KL; Horvath LG
JCO Oncol Pract; 2021 Feb; 17(2):e204-e216. PubMed ID: 32970524
[TBL] [Abstract][Full Text] [Related]
18. 'We don't know for sure': discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultations.
Medendorp NM; Hillen MA; van Maarschalkerweerd PEA; Aalfs CM; Ausems MGEM; Verhoef S; van der Kolk LE; Berger LPV; Wevers MR; Wagner A; Caanen BAH; Stiggelbout AM; Smets EMA
Fam Cancer; 2020 Jan; 19(1):65-76. PubMed ID: 31773425
[TBL] [Abstract][Full Text] [Related]
19. Patients' Medical and Psychosocial Experiences After Detection of a
Hamilton JG; Long JM; Brandt AC; Brower J; Symecko H; Salo-Mullen EE; Christian SN; Harstad T; Couch FJ; Garber JE; Offit K; Robson ME; Domchek SM
JCO Precis Oncol; 2019; 3():. PubMed ID: 31511843
[TBL] [Abstract][Full Text] [Related]
20. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]